Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.18 earnings per share for the quarter, Zacks reports. The firm had revenue of $6.01 billion during the quarter.
Fresenius SE & Co. KGaA Stock Down 1.8 %
Shares of FSNUY opened at $9.97 on Friday. Fresenius SE & Co. KGaA has a 12-month low of $6.57 and a 12-month high of $10.42. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. The company’s 50 day simple moving average is $9.35 and its 200-day simple moving average is $9.20.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. KGaA in a report on Monday, February 3rd.
About Fresenius SE & Co. KGaA
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Read More
- Five stocks we like better than Fresenius SE & Co. KGaA
- What is the MACD Indicator and How to Use it in Your Trading
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- Consumer Staples Stocks, Explained
- Why Smart Investors Are Watching These 3 Undervalued Stocks
- Best Aerospace Stocks Investing
- 3 Stocks Breaking Out with More Growth Potential Ahead
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
